Hyperinsulineamia as Risk Factor for Early Breast Cancer Recurrence Linked to Hormone Receptors and Human Epidermal Growth Factor Receptor 2

Journal Title: Journal of Diabetes and Obesity - Year 2017, Vol 4, Issue 3

Abstract

Background: Hyperinsuliunemia is a condition with excess levels of circulating insulin in the blood among non-diabetics. Hyperinsuliunemia may increase breast cancer developing probability. Purpose: to investigate the role of hyperinsuliunemia in early recurrence in breast cancer by estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). Methods: 50 patients with invasive breast cancer in stage II and III in age range 17 - 65 years, involved in this study and classified into five subtypes of ER, PR and HER2, and followed prospectively for 2 years from beginning treatment based on insulin serum levels. Results: In newly diagnosed patients the mean concentrations and standard deviation were (17.11 ± 10.17), while the insulin levels in the patients after chemotherapy treatment were (26.06 ± 15.69), when the tow means were compared by t. test the blood concentration of insulin was high significantly in patients as control (p > 0.001). Regarding hormone receptors and HER2, the insulin levels in ER−PR−HER2− and ER− PR−HER2+ increased significantly after chemotherapy (p = 0.005 and 0.047) respectively. 10 of triple negative breast cancer patients suffered recurrence. Conclusion: Hyperinsuliunemia and weight change after chemotherapy may consider as risk factors for breast cancer recurrence among patients with triple-negative breast cancer.

Authors and Affiliations

Alkhansa Salih Mahmoud

Keywords

Related Articles

Discovery of Adiponectin and its Future Prospect

Adiponectin is an adipocyte-specific protein abundantly present in the plasma. Since its discovery, numerous experimental and clinical studies have demonstrated that adiponectin has anti-atherogenic, antidiabetic and ant...

Association of Salivary and Plasma Glucose Level with Oral Health Status among Type 2 Diabetics in India - A Comparative Study

Background and Objectives: Diabetes is fast gaining the status of a potential epidemic in India with more than 62 million diabetic individuals currently diagnosed with the condition. Biochemical analysis of saliva would...

Exercise Intervention Improves the Metabolic Profile and Body Composition of Southwestern American Indian Adolescents

Introduction/Purpose: The Southwestern American Indian population carries a high prevalence of metabolic syndrome and obesity, placing this group at higher risk than the general population for developing early type 2 dia...

Determining the Development of Insulin Resistance in Older Adults of the NuAge cohort Using Trajectory Modeling of the Homeostatic Model Assessment of Insulin Resistance Score

Background: Age-associated body composition changes increase the risk of developing insulin resistance. Identifying these subjects in epidemiological studies is challenging. Objective: Identify insulin-resistant subjects...

Effect of Haematogenous oxidation therapy with Ultraviolet-C irridation in an alloxan-induced diabetes and a Poloxamer 407-induced Hyperlipidemia in rabbits

Background Recently diabetes and hyperlipidemia HL considered a major source of mortality Chemical treatments could minimize the symptoms but still the disease exists Previously Ultraviolet was usedfor treatment...

Download PDF file
  • EP ID EP418208
  • DOI 10.15436/2376-0494.17.1323
  • Views 93
  • Downloads 0

How To Cite

Alkhansa Salih Mahmoud (2017). Hyperinsulineamia as Risk Factor for Early Breast Cancer Recurrence Linked to Hormone Receptors and Human Epidermal Growth Factor Receptor 2. Journal of Diabetes and Obesity, 4(3), 0-0. https://europub.co.uk./articles/-A-418208